Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia

Saved in:

Bibliographic Details
Published in:	American journal of hematology Vol. 90; no. 7; pp. E131 - E132
Main Authors:	Aumont, Cédric, Driss, Françoise, Lazure, Thierry, Picard, Véronique, Creidy, Rita, De Botton, Stéphane, Saada, Véronique, Lambotte, Olivier, Bilhou‐Nabera, Chrystèle, Tertian, Gérard, Michot, Jean‐Marie
Format:	Journal Article
Language:	English
Published:	United States Wiley Subscription Services, Inc 01-07-2015
Subjects:	Anemia, Sickle Cell - complications Anemia, Sickle Cell - drug therapy Anemia, Sickle Cell - genetics Anemia, Sickle Cell - pathology Antineoplastic Agents - therapeutic use Antisickling Agents - therapeutic use Chromosome Aberrations Chromosomes, Human, Pair 17 Chromosomes, Human, Pair 5 Clone Cells Erythroblasts - metabolism Erythroblasts - pathology Fatal Outcome Granulocyte Precursor Cells - metabolism Granulocyte Precursor Cells - pathology Hematology Humans Hydroxyurea - therapeutic use Karyotype Leukemia, Erythroblastic, Acute - complications Leukemia, Erythroblastic, Acute - drug therapy Leukemia, Erythroblastic, Acute - genetics Leukemia, Erythroblastic, Acute - pathology Male Middle Aged Myelodysplastic Syndromes - complications Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - pathology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	Conflict of interest: The authors declare that no competing interests exist.
ISSN:	0361-8609 1096-8652
DOI:	10.1002/ajh.24010